What is the treatment for ringworm?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Ringworm

For ringworm (tinea corporis, tinea cruris, tinea pedis), topical antifungal therapy is the first-line treatment for localized infections, with systemic therapy reserved for extensive disease, scalp involvement, or treatment failures. 1, 2

Topical Therapy for Localized Infections

Topical antifungals are highly effective for limited skin infections and should be applied for 2-4 weeks depending on the site. 2, 3

  • Terbinafine cream is one of the most effective topical agents, requiring only 1-2 weeks of treatment compared to 2-4 weeks for azoles 2, 3
  • Azole antifungals (clotrimazole, miconazole, ketoconazole) applied twice daily are effective alternatives, with clotrimazole showing significantly higher cure rates than placebo (NNT 2) 3
  • Naftifine 1% demonstrates strong efficacy with mycological cure rates significantly better than placebo (NNT 3) 3

Treatment Duration by Site

  • Tinea corporis and tinea cruris: 2 weeks of topical therapy 2
  • Tinea pedis: 4 weeks with azoles or 1-2 weeks with allylamines (terbinafine, naftifine) 2
  • Continue treatment for at least 1 week after clinical clearing to prevent relapse 2

Systemic Therapy Indications

Oral antifungal therapy is required when topical treatment fails, infection is extensive, or specific sites are involved (scalp, nails, beard). 1, 4

When to Use Systemic Therapy

  • Tinea capitis (scalp ringworm) - topical therapy alone is inadequate 4, 5
  • Tinea barbae (beard area) - requires systemic treatment 6, 1
  • Tinea unguium (nail infections) 1
  • Widespread or resistant tinea corporis/cruris 1
  • Immunocompromised patients 7

Systemic Treatment Options

Griseofulvin remains the only FDA-approved systemic treatment for dermatophyte infections in children, though newer agents are increasingly used off-label. 1, 4

Griseofulvin Dosing (FDA-Approved)

  • Adults: 500 mg daily (can give as 125 mg four times daily, 250 mg twice daily, or 500 mg once daily) 1
  • Severe infections: May start with 750 mg to 1 g daily, then reduce to 500 mg after response 1
  • Children >2 years: 10 mg/kg daily (children 30-50 lbs: 125-250 mg daily; >50 lbs: 250-500 mg daily) 1

Treatment Duration with Griseofulvin

  • Tinea capitis: 4-6 weeks 1
  • Tinea corporis: 2-4 weeks 1
  • Tinea pedis: 4-8 weeks 1
  • Fingernails: At least 4 months 1
  • Toenails: At least 6 months 1

Alternative Systemic Agents (Off-Label for Most Indications)

  • Terbinafine: Requires only 6 weeks for tinea capitis versus 6-8 weeks with griseofulvin 4
  • Fluconazole 150-200 mg once daily for 2-4 weeks for extensive or severe fungal infections including tinea barbae 6
  • Itraconazole and fluconazole: Offer shorter treatment intervals with acceptable safety profiles 5

Critical Pitfalls to Avoid

Do not use topical corticosteroid-antifungal combinations for more than 2 weeks, and never use them in children under 12 years, on the face, or in occluded areas. 7

  • While combination products may provide faster symptom relief in heavily inflamed lesions, the corticosteroid can suppress local immunity and allow dermatophytes to persist or invade deeper 7
  • If using a combination product: Switch to pure antifungal once symptoms improve, limit to 2 weeks for tinea cruris and 4 weeks for tinea pedis/corporis 7
  • Contraindications for steroid combinations: Children <12 years, facial lesions, diaper areas, immunosuppressed patients 7

Diagnostic Confirmation Required

Always confirm dermatophyte infection with KOH preparation, fungal culture, or histology before initiating systemic therapy. 1

  • Griseofulvin is ineffective against Candida, bacteria, and other non-dermatophyte fungi 1
  • The drug should not be used for "minor or trivial" infections that respond to topical agents alone 1

Adjunctive Measures

Concomitant topical therapy and hygiene measures are essential to control reinfection sources, particularly for tinea pedis. 1

  • Address exacerbating factors such as skin moisture 2
  • Topical agents are usually required alongside systemic therapy for tinea pedis 1
  • Yeasts and bacteria may coexist with dermatophytes in tinea pedis and require separate treatment 1

References

Research

Topical treatment of common superficial tinea infections.

American family physician, 2002

Research

Topical antifungal treatments for tinea cruris and tinea corporis.

The Cochrane database of systematic reviews, 2014

Research

Pediatric tinea capitis: recognition and management.

American journal of clinical dermatology, 2005

Guideline

Fungal Infections of the Beard Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Topical therapy for dermatophytoses: should corticosteroids be included?

American journal of clinical dermatology, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.